Acura Pharmaceuticals Provides Update on FDA Discussions Surrounding Development of Aversion Hydrocodone With Acetaminophen Tablet
15 août 2014 06h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Aug 15, 2014) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR), announced today preliminary discussions from a meeting held with the U.S. Food and Drug Administration (FDA)...
Acura Pharmaceuticals Announces Second Quarter 2014 Financial Results
04 août 2014 16h05 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Aug 4, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals to Host Second Quarter 2014 Financial Results Conference Call on August 5, 2014
24 juil. 2014 16h05 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Jul 24, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company plans...
Acura Pharmaceuticals Provides Update on Its Abuse Deterrent Hydrocodone/Acetaminophen Combination Drug
27 mai 2014 17h00 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - May 27, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced the US Food and Drug Administration (FDA) advised the Company that the data from our...
Acura Pharmaceuticals Announces Settlement of Patent Litigation With Sandoz Inc.
21 mai 2014 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - May 21, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.
08 mai 2014 06h30 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - May 8, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals Announces First Quarter 2014 Financial Results
05 mai 2014 16h10 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - May 5, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals to Host First Quarter 2014 Financial Results Conference Call on May 6, 2014
28 avr. 2014 15h40 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Apr 28, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company plans...
Acura Pharmaceuticals Announces Return of Product Rights
10 avr. 2014 06h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Apr 10, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals to Present at the 26th Annual ROTH Conference
05 mars 2014 14h00 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - Mar 5, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...